Dear Fellow Readers / Friends,
On 21 Feb, my comments on Healthcare Stocks:
Faber, KPJ and IHH - P/E is too high, I will Keep in View
YSP & CCM - Good dividend & Good FA, I will Monitor/Consider
APEX, PETERLABS, Pharma - I will Keep in view (I may consider if quarterly earnings improved and with new catalysts) -Neutral
Hovid - P/E is high but having catalysts - I May Monitor/Consider.
Fast forward, let's look at the result for 21 Feb VS 1st May 2015:
YSP increased 0.17cents = 12%
CCMBIO increased = 35.7%
Hovid increased = 13.6%
The one DID NOT recommended but the prices did shoot up:
Apex Healthcare, Peterlabs, PHARMA, Focus Point and Careplus
All hospital stocks: Faber, KPJ and IHH
From this exercise, we did MISS A LOT OF OPPORTUNITIES for ignoring other healthcare stocks. But looking at the call for YSP, CCMBIO and HOVID we are SATISFIED with the results. Fundamental approach is always meant for a more tightening stock selection basis. We are still maintaining our stocks selection method in a more stringent way.
(To note, personally did not manage to buy Hovid - was monitoring for too long - the one that got away).